DCF — MERCY MEDICAL CENTER
Enterprise Value: $-118.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-118.0M
Enterprise Value
$-43.4M
PV of Cash Flows
$-74.6M
PV of Terminal Value
$-120.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $254.5M | $-4.0M | -2.0% | $-14.8M | $-13.5M |
| Year 2 | $262.1M | $-1.5M | -1.0% | $-12.6M | $-10.4M |
| Year 3 | $270.0M | $1.1M | 0.0% | $-10.3M | $-7.7M |
| Year 4 | $278.1M | $2.5M | 1.0% | $-9.2M | $-6.3M |
| Year 5 | $286.5M | $3.3M | 1.0% | $-8.8M | $-5.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-118.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$247.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.02084254321466935
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5